An Open-label, Multiple-Dose Escalation Trial to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of ONO-7746 in Adult Cancer Patients With Chemotherapy Induced Thrombocytopenia
Latest Information Update: 16 Dec 2015
At a glance
- Drugs NIP 022 (Primary)
- Indications Thrombocytopenia
- Focus Adverse reactions
- Sponsors Ono Pharmaceutical
Most Recent Events
- 16 Dec 2015 New trial record